COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation

Miesbach, W. and Makris, M. orcid.org/0000-0001-7622-7939 (2020) COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clinical and Applied Thrombosis/Hemostasis, 26. ISSN 1076-0296

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2020. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: COVID-19; thrombosis; anticoagulation
Dates:
  • Accepted: 8 June 2020
  • Published (online): 17 July 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 29 Jul 2020 14:10
Last Modified: 29 Jul 2020 14:10
Status: Published online
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/1076029620938149
Related URLs:

Share / Export

Statistics